OCC 2.34% 62.5¢ orthocell limited

Ann: Successful OrthoATI clinical trial, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 801 Posts.
    lightbulb Created with Sketch. 167
    No update for OrthoATI - rotator cuff since last year. Management have been cutting 'n pasting the same paragraph for 1 year now.
    Surely, they can give us an update for the "pathway to commercialisation" by now.
    What is the progress for the Phase IIb Randomised Control study?

    Great results today and hopefully OrthoATI- lateral epicondylitis can piggyback onto OrthoATI - rotator cuff which looks like it is about 1 year ahead, research/approval-wise.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
62.5¢
Change
-0.015(2.34%)
Mkt cap ! $149.4M
Open High Low Value Volume
64.5¢ 64.5¢ 62.0¢ $124.1K 195.2K

Buyers (Bids)

No. Vol. Price($)
2 12045 62.5¢
 

Sellers (Offers)

Price($) Vol. No.
64.0¢ 20258 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.